Back to Search
WAYNE FRANKLIN, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1649208521IndividualAccepts Medicare
Specialties, Licenses & Credentials
Adult Congenital Heart Disease Physician
Internal Medicine — Adult Congenital Heart Disease
Code: 207RA0002X
57045(AZ)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
L4378(TX)MD500003328(DC)
Pediatric Cardiology Physician
Pediatrics — Pediatric Cardiology
Code: 2080P0202X
57045(AZ)L4378(TX)
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Education
OTHER
Class of 1997
Research & Publications (20)
Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy.
PMID 18990508·Int J Radiat Oncol Biol Phys·2009
5-case
The contribution of a urine-based jail screening program to citywide male Chlamydia and gonorrhea case rates in New York City.
PMID 17989586·Sex Transm Dis·2009
8-other
B-type natriuretic peptide and heart failure in patients with ventricular septal defect: a pilot study.
PMID 19636481·Pediatr Cardiol·2009
8-other
KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection.
PMID 19124802·J Clin Oncol·2009
6-review
Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.
PMID 19541651·Proc Natl Acad Sci U S A·2009
7-preclinical
Device management of arrhythmias after Fontan conversion.
PMID 19660377·J Thorac Cardiovasc Surg·2009
8-other
Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer.
PMID 19547694·PLoS One·2009
8-other
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLC.
PMID 19476276·Oncology (Williston Park)·2009
5-case
EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.
PMID 19247083·J Thorac Oncol·2009
4-observational
A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.
PMID 19401528·Cancer Prev Res (Phila)·2009
3-trial
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
PMID 19255321·J Clin Oncol·2009
3-trial
A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
PMID 18618507·Cancer·2008
4-observational
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.
PMID 18758306·J Thorac Oncol·2008
3-trial
Charge form factor of the neutron at low momentum transfer from the 2H-->(e-->,e'n)1H reaction.
PMID 18764321·Phys Rev Lett·2008
8-other
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
PMID 18612151·J Clin Oncol·2008
3-trial
First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.
PMID 18520298·J Thorac Oncol·2008
6-review
Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.
PMID 18390968·J Clin Oncol·2008
3-trial
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance.
PMID 18342661·Hum Pathol·2008
8-other
Impact of manufacturer advisories and FDA recalls of implantable cardioverter defibrillator generators in pediatric and congenital heart disease patients.
PMID 18691353·J Cardiovasc Electrophysiol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1919 E THOMAS RD
PHOENIX, AZ 85016 - Phone
- (602) 933-3366
Quick Facts
- NPI
- 1649208521
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 5
- Locations
- 3
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile